Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Histogen Inc (EM) HSTOQ

Industrials Conglomerates
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. The company’s product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:HSTOQ)

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering

GlobeNewswire April 18, 2024

Histogen Announces Second Adjournment of Special Meeting of Stockholders

GlobeNewswire December 14, 2023

Histogen Announces Adjournment of Special Meeting of Stockholders

GlobeNewswire December 5, 2023

Histogen Announces Board Approval of Complete Liquidation and Dissolution

GlobeNewswire September 18, 2023

Histogen to Explore Strategic Alternatives

GlobeNewswire July 5, 2023

Histogen Reports First Quarter 2023 Results and Provides Business Update

GlobeNewswire May 11, 2023

Histogen Announces Online Publication in the Journal of Investigative Dermatology

GlobeNewswire April 20, 2023

Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University

GlobeNewswire April 3, 2023

Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use

GlobeNewswire March 16, 2023
View More News ››

Opinion & Analysis (EXPM:HSTOQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:HSTOQ)

HSTO ..... Thanks for the dough Joe

Cheers to scalping   Money for nothing !
Iseneschal - March 17, 2023

HSTO ....in some here at sub $1.29

C what happens
Iseneschal - March 17, 2023

HSTO ..... U have to ask yourself....

How on earth does this trade 10 x's it's shares o/s and only be up 45 f'king cents  I smell a rat !!!!!!!!!!!!!!!!!!!!!...
Iseneschal - March 17, 2023

HSTO..... I call this "No Mans Land"

I'm fairly certain of the direction....keeping that to myself for this moment.... $1.31  Cheers !
Iseneschal - March 17, 2023

HSTO ..... just remember that this still isn't Strike 3 ; )

The last bastion of support hasn't been breached yet  Might still have legs
Iseneschal - March 17, 2023

HSTO...... Lol.... I rest my case

U know now !
Iseneschal - March 17, 2023
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of lithium ...
View More »